Top Tweets for #fdasla
The 4,000 beagles rescued from being used for testing is another reason why we need our Congressional leaders to remove a provision in the #FDASLA Act of 2022 that would preempt, or erase, existing state restrictions on animal testing for cosmetics.
https://t.co/14Y2PSLYOI
#USA: The ironically named Food and Drug Administration Safety and Landmark Advancements Act (#FDASLA Act of 2022), includes a disastrous provision that would undo & prevent state laws that ban the sale of animal-tested #cosmetics.
Take Action https://t.co/5rR3RBCVai
The letter we sent to Senate @HELPCmteDems and @GOPHELP is more relevant than ever, every Senator should care about these 5 ways to strengthen #FDASLA: https://t.co/d818cTCIoX
BREAKING NEWS: The HELP Committee advances S. 4348, the @US_FDA Safety and Landmark Advancements (#FDASLA) Act with @SenatorBaldwin’s #RAREAct amendment. Thank you Senator Baldwin for your amendment and commitment to the #RareDisease community!
.@HELPCmteDems & @GOPHELP should strengthen #FDASLA by: automatically withdrawing accelerated approval drugs if clinical benefit isn’t confirmed, maintaining randomized controlled trials as gold standard for demonstrating effectiveness, & increasing clinical trials diversity.
Our #FDATaskForce will be tuning in to the postponed @HELPCmteDems and @GOPHELP #FDASLA markup! Hope they used the extra time to strengthen accelerated approval and include clinical trial diversity in the bill!
NEWS: The Senate HELP Committee has postponed the #FDASLA markup to next week. That means there’s even more time to help strengthen the legislation by adding #clinicaltrial diversity provisions! ⏱️
@melmillerphd @PattyMurray @SenatorBurr @GOPHELP @HELPCmteDems For sure! Exempting Academic & Hospital-based labs from #VALIDAct is a minimum, but still fails to modernize #CLIA. Separating it from #FDASLA would allow the fulsome debate this complex issue warrants!
Most of today’s medical decisions depend on lab tests. The #VALIDAct will impair our ability
to provide these critical services to patients. @PattyMurray @HELPCmteDems @SenatorBurr
@GOPHELP, remove the VALID Act from #FDASLA. 2016-2017 Board of Directors
Here's what we at the DFA FDA Task Force sent to @HELPCmteDems @GOPHELP this week calling for the strengthening of reforms to the accelerated approval pathway and measures to ensure (as well as enforce) clinical trial diversity to be included in the final version of #FDASLA.
All eyes on #PDUFA in both chambers this week! The #FDATaskForce is crossing our collective fingers that @SenateHELP and @GOPHELP put patients first by strengthening #FDASLA https://t.co/lnE6qtFv2X
My @CSUEastBay #PharmaPolicy students sent policy memos to @SenFeinstein @SenAlexPadilla and their Representatives (including @RoKhanna @RepSwalwell @RepJuanVargas @RepBera @RepBarbaraLee) highlighting 3 policy issues for #FDASLA
Clinical trial diversity was a top priority!
All the more reason for @HELPCmteDems @GOPHELP to include provisions requiring clinical trial diversity in the final version of the @US_FDA user fee bill (#FDASLA) - without enforcement, industry sponsors will only keep finding excuses to not enroll indicated patient subgroups.
All the more reason for @HELPCmteDems @GOPHELP to include provisions requiring clinical trial diversity in the final version of the @US_FDA user fee bill (#FDASLA) - without enforcement, industry sponsors will only keep finding excuses to not enroll indicated patient subgroups.
The majority of Black women with metastatic breast cancer don’t get enrolled into clinical trials, according to new research presented at #ASCO22 on Monday. Only 40% of Black respondents said they were even offered a trial. https://t.co/GfMAfQrBHv
Here's my #MemorialDayWeekend - @HELPCmteDems @GOPHELP drop 2nd #FDASLA draft:
👍 accelerated approval reforms, mirrors @EnergyCommerce bill, added an AA council
👎 no auto expiration for unproven AA drugs, allows RWE for postapproval studies
👎 0 on clinical trial diversity 🤦🏾♀️
We support @drsforamerica's recommendations for the FDA Safety and Landmark Advancements (#FDASLA) Act. Senate HELP Committee (@HELPCmteDems @GOPHELP) should include provisions for reforming the @US_FDA accelerated approval pathway and improving clinical trial diversity. #PDUFA
(1/5) AAM FDASLA STATEMENT: “@AccessibleMeds and its @BiosimsCouncil commend Chair @PattyMurray and Ranking Member @SenatorBurr for their bipartisan leadership on the discussion draft of the FDA Safety and Landmark Advancements (#FDASLA) Act. 🧵
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.5M followers
Barack Obama
@barackobama
118.8M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.3M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.3M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.7M followers